Browsing: Candidate

Ultragenyx Pharmaceutical (NASDAQ: RARE) and Mereo BioPharma Group (NASDAQ: MREO) may be wishing for a happy new year in 2026…

Early biomarker engagement and clean safety data position VNA-318 as a potential new entrant in longevity-focused neurotherapeutics. Vandria has reported…

Credit: vshivkova/Getty Images Researchers at the Garvan Institute of Medical Research in Sydney, Australia, have discovered that an existing cancer…

uniQure has acknowledged that what it called “game changing” data in September showing significant slowing of Huntington’s disease (HD) progression…

Credit: Juan Gaertner / Getty Images / Science Photo Library Researchers at the Francis Crick Institute and Vividion Therapeutics have…